RESUMO
A unique case of eyelid metastasis from nasopharyngeal chondroid chordoma in a 63-year-old woman was reported. Chordomas are rare tumors of the bone deriving from remnants of the embryonic notochord. Histologically, the tumor showed lobulated structure and concludes two types of cells: liquid drop cell and small round/cubic cell. Immunohistochemically, AE1/AE3, epithelial membrane antigene (EMA), and S100 showed a uniform and strong positivity. It has a great capacity for recurrence and malignant transformation, despite their slow-growing nature. The most common sites of metastases are liver, lungs, and bones. The eyelid metastasis from chordoma is an extremely rare finding, which may suggest a poor prognosis for the patient. Its significant clinicopathological characteristic could prompt us to take it into consideration when assessing the patient's prognosis.
RESUMO
OBJECTIVE: Emerging evidence has shown that the F‑box protein S‑phase kinase‑associated protein 2 (Skp2) plays an important role in the pathogenesis of breast cancer (BC). Our study aimed to evaluate the prognostic value of Skp2 in BC patients using meta‑analysis based on the published studies. MATERIALS AND METHODS: Eligible studies were identified by searching the online databases such as PubMed, EMBASE, and Web of Science up to October 2015. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to clarify the correlation between Skp2 expression and indicators of BC clinical outcomes, including overall survival (OS), disease‑free survival (DFS), and BC‑specific survival. RESULTS: In total, nine studies with 1820 BC patients were included for final analysis. The meta‑analysis suggested that Skp2 overexpression was associated with poor OS (HR = 2.58, 95% CI: 1.83–3.63, P = 0.000) and poor DFS (HR = 2.12, 95% CI: 1.48–3.05, P = 0.000) in BC patients. CONCLUSIONS: This meta‑analysis indicates that enhanced Skp2 is an independent prognostic factor for poor cancer survival.